Current Cancer Drug Targets

Editor-in-Chief

Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
(USA)

Personal Subscription
Become EABM
Become Reviewer

Targeting Oncogenes and Tumor Suppressors genes to Mitigate Chemoresistance

Volume:14   Issue: 7
Pp: 599-609
Tahereh Fatemian and Ezharul Hoque Chowdhury
DOI: 10.2174/156800961407140926104458


The Role of CD40 Expression in Dendritic Cells in Cancer Biology; A Systematic Review

Volume:14   Issue: 7
Pp: 610-620
Gui Han Lee, Alan Askari, George Malietzis, David Bernardo, Susan K. Clark, Stella C. Knight and Hafid Omar Al-Hassi
DOI: 10.2174/1568009614666140828103253


The Important Roles of miR-205 in Normal Physiology, Cancers and as a Potential Therapeutic Target

Volume:14   Issue: 7
Pp: 621-637
Haleh Vosgha, Ali Salajegheh, Robert Anthony Smith and Alfred King-Yin Lam
DOI: 10.2174/156800961407140926105634


Analogs of Cinnamic Acid Benzyl Amide As Nonclassical Inhibitors of Activated JAK2 Kinase

Volume:14   Issue: 7
Pp: 638-651
Marcin Mielecki, Małgorzata Milner-Krawczyk, Krystyna Grzelak, Damian Mielecki, Krystiana A. Krzysko, Bogdan Lesyng and Waldemar Priebe
DOI: 10.2174/1568009614666140821122718


Deregulated Expression of miR-224 and its Target Gene: CD59 Predicts Outcome of Diffuse Large B-cell Lymphoma Patients Treated with R-CHOP

Volume:14   Issue: 7
Pp: 659-670
Guoqi Song, Guorong Song, Huiyun Ni, Ling Gu, Hong Liu, Baoan Chen, Bangshun He, Yuqin Pan, Shukui Wang and William C. Cho
DOI: 10.2174/1568009614666140818211103


Antiproliferative Effect of HSP90 Inhibitor Y306zh Against Pancreatic Cancer is Mediated by Interruption of AKT and MAPK Signaling Pathways

Volume:14   Issue: 7
Pp: 671-683
Nina Xue, Jing Jin, Di Liu, Rui Yan, Sen Zhang, Xiaoming Yu and Xiaoguang Chen
DOI: 10.2174/1568009614666140908101523